|
02 Apr 2008 |
Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis
|
|
01 Apr 2008 |
ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of
|
|
31 Mar 2008 |
Naglazyme Approved by Japanese Ministry of Health
|
|
27 Mar 2008 |
GTC Biotherapeutics and PharmAthene Extend Agreement for Protexia Program
|
|
27 Mar 2008 |
Positive phase III data unveiled for new GnRH blocker degarelix
|
|
27 Mar 2008 |
OMRIX Biopharmaceuticals Initiates Phase II Clinical Trial for Fibrin Patch Product Candidate
|
|
26 Mar 2008 |
Æterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
|
|
26 Mar 2008 |
SemBioSys initiates toxicology study for safflower-produced insulin
|
|
26 Mar 2008 |
Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
|
|
20 Mar 2008 |
Pharming To Receive Negative Opinion On European Marketing Authorization Application For Rhucin(R)
|
|
20 Mar 2008 |
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
|
|
19 Mar 2008 |
Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
|
|
18 Mar 2008 |
Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
|
|
18 Mar 2008 |
Biolex Announces Presentation of Preclinical Results for Clot Buster BLX-155 at SIR Annual Scientific Meeting
|
|
17 Mar 2008 |
Ipsen and Medicis Announce Submission of Reloxin BLA in Aesthetics to the FDA
|
|
17 Mar 2008 |
Phylogica and Dynamic Microbials sign anti-bacterial deal
|
|
17 Mar 2008 |
Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
|
|
14 Mar 2008 |
Merrimack Pharmaceuticals Completes Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
|
|
14 Mar 2008 |
MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
|
|
14 Mar 2008 |
Teva Provides Update On Glatiramer Acetate 40mg For Amyotrophic Lateral Sclerosis (Als)
|
|
12 Mar 2008 |
Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin
|
|
11 Mar 2008 |
Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
|
|
11 Mar 2008 |
OctoPlus announces publication of Phase I Locteron results in the Journal of Interferon and Cytokine Research
|
|
10 Mar 2008 |
Palatin Technologies, Inc. Reports positive results of a Phase I clinical study with PL-3994 for the treatment of congestive heart failure
|
|
10 Mar 2008 |
Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
|
